Zusammenfassung
»Für die Entstehung der Tumorzelle sind offenbar Vorgänge an bestimmten Strukturen im Zellplasma und Kern entscheidend« (Domagk 1956). Trotz seines Alters hat dieser Satz auch heute noch uneingeschränkte Aktualität. Die Eigenschaften von Zellen und Geweben werden im Wesentlichen durch das Zusammenspiel der in diesen Zellen und Geweben vorliegenden Proteine bestimmt. Unterschiede in der Zusammensetzung und im Zustand dieser Proteine zwischen Tumorzellen und den entsprechenden normalen Zellen sind nach unserer heutigen Vorstellung für Tumorentstehung und -progression entscheidend verantwortlich. Diese Parameter werden durch genetische und epigenetische Mechanismen gesteuert. Die Aufklärung solcher Mechanismen — keineswegs beschränkt auf Fragen der Krebsforschung — ist Gegenstand der relativ neuen Forschungsgebiete der funktionellen Genomik und Proteomik.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agami R (2002) RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Bio 6: 829–834
Alizadeh AA, Ross DT, Perou CM, van de Rijn M (2001) Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195:41–52
Beer DG, Kardia SL, Huang CC et al (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8:816–824
Bennetzen J (2002) Opening the door to comparative plant biology. Science 296:60–63
Boguski MS, McIntosh MW (2003) Biomedical informatics for proteomics. Nature 422:233–237
Butenand A, Dannenberg H (1956) Die Biochemie der Geschwülste. In: Büchner, F, Letterer, E, Roulet, F (Hrsg) Handbuch der allgemeinen Pathologie, Band 6, Teil 3, S 107–241. Springer, Berlin Heidelberg
Butte A (2002) The use and analysis of microarray data. Nat Rev Drug Discov 1:951–960
Domagk G (1956) Die experimentelle Geschwulstforschung. In: Büchner, F, Letterer E, Roulet F (Hrsg) Handbuch der allgemeinen Pathologie, Band 6, Teil 3, S 242–367. Springer, Berlin Heidelberg
Elkahloun AG, Gaudet J, Robinson GS, Sgroi DC (2002) In situ gene expression analysis of cancer using laser capture microdissection, microarrays and real time quantitative PCR. Cancer Biol Ther 1:354–358
Erickson AC, Barcellos-Hoff MH (2003) The not-so innocent bystander: the microenvironment as a therapeutic target in cancer. Expert Opin Ther Targets 7:71–88
Evans SJ, Datson NA, Kabbaj M et al (2002) Evaluation of Affymetrix gene chip sensitivity in rat hippocampal tissue using SAGE analysis. Serial analysis of gene expression. Eur J Neurosci 16:409–413
Fodor SP, Read JL, Pirrung MC et al (1991) Light-directed, spatially addressable parallel chemical synthesis. Science 251:767–773
Futcher B, Latter GI, Monardo P et al (1999) A sampling of the yeast proteome. Mol Cell Biol 19: 7357–7368
Griffin TJ, Gygi SP, Ideker T et al (2002) Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 1:323–33
Gygi SP, Rochon Y, Franza BR, Aebersold R (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720–1730
Hanash S (2003) Disease proteomics. Nature 422:226–232
Ishi M, Hashimoto S, Tsutsumi S et al (2000) Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics 68:136–143
Kashani-Sabet M (2002) Ribozyme therapeutics. J Investig Dermatol Symp Proc 7:76–78
Khan J, Wei JS, Ringner M et al (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7:673–679
Klose J (1975) Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26:231–243
Knezevic V, Leethanakul C, Bichsel VE et al (2001) Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1:1271–1278
Kojima T, Asami S, Chin M et al (2002) Detection of chimeric genes in Ewing’s sarcoma and its clinical applications. Biol Pharm Bull 25:991–994
Kusnezow W, Jacob A, Walijew A et al (2003) Antibody microarrays: An evaluation of production parameters. Proteomics 3:254–264
Liang DC, Shih LY, Yang CP et al (2002) Multiplex RT-PCR assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia. Med Pediatr Oncol 39:12–17
Liebig B, Brabletz T, Staege MS et al (2005) Forced expression of DeltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin. Cancer Lett 223:159–167
MacBeath G (2002) Protein microarrays and proteomics. Nat Genet 32(Suppl):526–532
Menssen A, Hermeking H (2002) Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci USA 99:6274–6279
Morris EC, Bendle GM, Stauss HJ (2003) Prospects for immunotherapy of malignant disease. Clin Exp Immunol 131:1–7
Milenic DE (2002) Monoclonal antibody-based therapy strategies: providing options for the cancer patient. Curr Pharm Des 8:1749–1764
Mullen JT, Tanabe KK (2002) Viral oncolysis. The Oncologist 7:106–119
Nishimori H, Sasaki Y, Yoshida K et al (2002) The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene 21:8302–8309
Oberbauer R (1997) Not nonsense but antisense — applications of antisense oligonucleotides in different fields of medicine. Wien Klin Wochenschr 109:40–46
O’Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007–4021
Ohali A, Avigad S, Zaizov R et al (2004) Prediction of high risk Ewing’s sarcoma by gene expression profiling. Oncogene 23:8997–9006
Orr MS, Scherf U (2002) Large-scale gene expression analysis in molecular target discovery. Leukemia 16: 473–477
Peter M, Gilbert E, Delattre O (2001) A multiplex real-time pcr assay for the detection of gene fusions observed in solid tumors. Lab Invest 81:905–912
Pindolia VK, Zarowitz BJ (2002) Imatinib mesylate, the first molecularly targeted gene suppressor. Pharmacotherapy 22:1249–1265
Sadovnikova E, Parovichnikova EN, Savchenko VG et al (2002) the CD68 protein as a potential target for leukaemia-reactive CTL. Leukemia 16:2019–2026
Sawyers CL (2002) Rational therapeutic intervention in cancer: kinases as drug targets. Curr Opin Genet Dev 12:111–115
Schäfer KL, Wai DH, Poremba C et al (2002) Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays. Virchows Arch 440:476–484
Schena M, Davis RW (1999) Genes, genomes, and chips. In: Schena, M. (ed) DNA microarrays. A practical approach, pp.1–16. Oxford University Press, Oxford
Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467–470
Schuhmacher M, Kohlhuber F, Holzel M et al (2001) The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res 29:397–406
Shiio Y, Donohoe S, Yi EC et al (2002) Quantitative proteomic analysis of Myc oncoprotein function. EMBO J 21:5088–5096
Shtutman M, Zhurinsky J, Oren M et al (2002) PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription. Cancer Res 62:5947–5954
Staege MS, Burdach S (2003) Gegenwart und Zukunft der molekularen Therapie. Vom Genom zum Antigenom. Kinder-und Jugendmedizin 3:216–220
Staege MS, Hattenhorst UE, Neumann I et al (2003) DNA-Microarrays as tools for the identification of tumor specific gene expression profiles: Applications in tumor biology, diagnosis and therapy. Klin Pädiatr 215: 135–138
Staege MS, Hutter C, Neumann I et al (2004) DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64:8213–8221
Storz G (2002) An expanding universe of noncoding RNAs. Science 296:1260–1263
Theriault TP, Winder SC, Gamble RC (1999) Application of ink-jet printing technology to the manufacture of molecular arrays. In: Schena M (ed) DNA microarrays. A practical approach, pp 101–120. Oxford University Press, Oxford
Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99:6567–6572
van der Vijver MJ, He YD, van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009
Wai DH, Schäfer KL, Schramm A et al (2002) Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int J Oncol 20:441–451
Watson JD, Oster SK, Shago M et al (2002) Identifying genes regulated in a Myc-dependent manner. J Biol Chem 277:36921–36930
Weinschenk T, Gouttefangeas C, Schirle M et al (2002) Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res 62:5818–5827
Yagyu R, Hamamoto R, Furukawa Y, Okabe H, Yamamura T, Nakamura Y (2002) Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. Int J Oncol 20:1173–1178
Ye SQ, Usher DC, Zhang LQ (2002) Gene expression profiling of human diseases by serial analysis of gene expression. J Biomed Sci 9:384–394
Yeoh EJ, Ross ME, Shurtleff SA et al (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1:133–143
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Burdach, S., Staege, M.S. (2006). Funktionelle Genomik und Proteomik. In: Gadner, H., Gaedicke, G., Niemeyer, C., Ritter, J. (eds) Pädiatrische Hämatologie und Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29036-2_49
Download citation
DOI: https://doi.org/10.1007/3-540-29036-2_49
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-03702-6
Online ISBN: 978-3-540-29036-0
eBook Packages: Medicine (German Language)